Antibiotics and Probiotics Prophylaxis for Recurrent Urinary Tract Infection in Children
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Since many years, continuous low dose antibiotic prophylaxis (CAP) has been used for children at a risk for recurrent urinary tract infection (UTI), especially those with vesicoureteral reflux (VUR). The incidence of recurrent UTI has been shown to be higher in children with VUR with bladder and bowel dysfunction (BBD) than in those with VUR without BBD. Therefore, CAP has been recommended for children with BBD and VUR because of the increased risk of UTI. However, the use of CAP has become highly controversial because of bacterial resistance developed due to antibiotic over-usage. The preventive effects of probiotics have been proved in various adult urogenital infections, and the antimicrobial activities of lactobacilli against uropathogens have been demonstrated in previous in vitro studies. However, a critical assess ment of their efficacy in children with UTI is lacking. The importance of the use of urogenital probiotics is that it is a natural approach that replenishes the depleted normal flora to create a better environment to fight off uropathogens. Probiotics have a great potential, particularly today with the increasing threat of antibioticresistant microorganisms.
Abstract
Since many years, continuous low dose antibiotic prophylaxis (CAP) has been used for children at a risk for recurrent urinary tract infection (UTI), especially those with vesicoureteral reflux (VUR). The incidence of recurrent UTI has been shown to be higher in children with VUR with bladder and bowel dysfunction (BBD) than in those with VUR without BBD. Therefore, CAP has been recommended for children with BBD and VUR because of the increased risk of UTI. However, the use of CAP has become highly controversial because of bacterial resistance developed due to antibiotic over-usage. The preventive effects of probiotics have been proved in various adult urogenital infections, and the antimicrobial activities of lactobacilli against uropathogens have been demonstrated in previous in vitro studies. However, a critical assess ment of their efficacy in children with UTI is lacking. The importance of the use of urogenital probiotics is that it is a natural approach that replenishes the depleted normal flora to create a better environment to fight off uropathogens. Probiotics have a great potential, particularly today with the increasing threat of antibioticresistant microorganisms.
참고문헌 (30)
- Subcommittee on urinary tract infection, steering committee on quality improvement and management, "Urinary tract infection : clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months", Pediatrics, 128, pp.595~610 (2011)
- Elder JS, "Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children", J Urol, 157, pp.1846~1851 (1997)
- Williams GJ, "Long-term antibiotics for preventing recurrent urinary tract infection in children", Cochrane Database Syst Rev, 3, pp.CD001534~ (2006)
- Mattoo TK, "Evidence for and against urinary prophylaxis in vesicourethral reflux", Pediatr Nephrol, 25, pp.2379~2382 (2010)
- Garin EH, "Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis : a multicenter, randomized, controlled study", Pediatrics, 117, pp.626~632 (2006)
- Roussey-Kesler G, "Antibioic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux : Results from a prospective randomized study", J Urol, 179, pp.674~679 (2008)
- Pennesi M, "North East Italy prophylaxis in VUR study groups. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, conrolled trial", Pediatrics, 121, pp.e1489~e1494 (2008)
- Montini G, "Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, non-inferiority trial", Pediatrics, 122, pp.1064~1071 (2008)
- Ladhani S, "Increasing antibiotic resistance among urinary tract isolates", Arch Dis Child, 88, pp.444~445 (2003)
- "Evaluation of health and nutritional properties of probiotics in food including powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United States and World Health Organization Expert consultation Report" (2001)[URL]
- Craig JC, "Antibiotic prophylaxis and recurrent urinary tract infection in children", N Eng J Med, 361, pp.1748~1759 (2009)
- Branstrom P, "The Swedish reflux trial in children: IV. Renal damage", J Urol, 184, pp.292~297 (2010)
- Peters CA, "Summary of the AUA guideline on management of primary vesicoureteral reflux in children", J Urol, 84, pp.1134~1144 (2010)
- Koff SA, "The relationship among dysfunctional elimination syndrome, primary vesicoureteral reflux and urinary tract infection in children", J Urol, 160, pp.1019~1022 (1998)
- Chen JJ, "A multivariate analysis of dysfunctional elimination and its relationships with gender, urinary tract infection and vesicoureteral reflux in children", J Urol, 171, pp.1907~1910 (2004)
- Avlan D, "Relationship among vesicoureteral reflux, urinary tract infection and renal injury in children with non-neurogenic lower urinary tract dysfunction", J Pediatr Urol, 7, pp.612~615 (2011)
- Van Batavia JP, "Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction", J Urol, 190, pp.1495~1500 (2013)
- Matsuzaki T, "Modulating immnune response with probiotic bacteria", Immunol Cell Biol, 78, pp.67~73 (2000)
- Amdekar S, "Probiotic Therapy : Immunomodulating approach toward urinary tract infection", Curr Microbiol, 63, pp.484~490 (2011)
- Bruce AW, "Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infection", Can J Microbiol, 34, pp.49~52 (1988)
- Gupta K, "Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in woman with recurrent urinary tract infections", J Infect Dis, 178, pp.446~450 (1998)
- Reid G, "Oral use of L. rhamnosus GR-1 and L. fermentum RC-14 significantly laters vaginal flora: randomized, placebo-controlled trial in 64 healthy woman", FEMS Immunol Med Microbiol, 35, pp.131~134 (2003)
- Reid G, "Prevention of urinary tract infection in rats with indigenous Lactobacillus casei strain", Infect Immune, 49, pp.320~324 (1985)
- Asahara T, "Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection", Antimicrobial Agents Chemother, 45, pp.1751~1760 (2001)
- Fraga M, "Preventive and therapeutic administration of an indigenous lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model", Antonie Van Leeuwenhoek, 88, pp.25~34 (2005)
- Marild S, "Protective effect of breastfeeding against urinary tract infection", Acta Paediatr, 93, pp.164~168 (2004)
- Dani C, "Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study", Biol Neonate, 82, pp.103~108 (2002)
- Gerasimov SV, "Probiotic prophylaxis in pediatric recurrent urinary tract infection", Clin Pediatr, 43, pp.95~98 (2004)
- Lee SJ, "Probiotics prophylaxis in children with persistent primary vesicoureteralreflux", Pediatr Nephrol, 22, pp.1315~1320 (2007)
- Lee JW, "Lactobacillus colonization status in infants with urinary tract infection", Pediatr Nephrol, 24, pp.135~139 (2009)